Showing results (191-200 of 198) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 198 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2013
Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II studyJean Louis Lefebvre, Yoann Pointreau, Frederic Rolland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancerBenjamin J Moeller, Vishal Rana, Blake A Cannon, et al.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2010
Prospective imaging assessment of mortality risk after head-and-neck radiotherapyBenjamin J Moeller, Vishal Rana, Blake A Cannon, et al.
Molecular Cancer Therapeutics|June 10, 2010
Serum signature of hypoxia-regulated factors is associated with progression after induction therapy in head and neck squamous cell cancerLauren Averett Byers, F Christopher Holsinger, Merrill S Kies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522K Kian Ang, Qiang Zhang, David I Rosenthal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2014
Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypesMichaela K Keck, Zhixiang Zuo, Arun Khattri, et al.
Radiation Research|November 19, 2004
Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3-4, 2003Helen B Stone, John E Moulder, C Norman Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2012
An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistanceLauren Averett Byers, Lixia Diao, Jing Wang, et al.
Pageof 20